CapWealth Advisors LLC Lowers Holdings in The Clorox Company (NYSE:CLX)

CapWealth Advisors LLC lessened its stake in The Clorox Company (NYSE:CLXFree Report) by 6.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,768 shares of the company’s stock after selling 121 shares during the period. CapWealth Advisors LLC’s holdings in Clorox were worth $287,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC grew its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the period. Asset Planning Inc purchased a new stake in Clorox in the 4th quarter worth $32,000. Finally, Carolina Wealth Advisors LLC acquired a new position in Clorox during the third quarter worth $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 1.9 %

Shares of Clorox stock opened at $147.91 on Friday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The firm has a market capitalization of $18.31 billion, a price-to-earnings ratio of 40.41, a PEG ratio of 2.52 and a beta of 0.42. The stock has a 50 day moving average of $159.55 and a 200 day moving average of $159.13.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business posted $2.16 earnings per share. As a group, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th were paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.30%. The ex-dividend date was Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 133.33%.

Wall Street Analysts Forecast Growth

Several research firms have commented on CLX. JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $158.21.

Get Our Latest Stock Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.